Entacapone provides benefit to Parkinson's disease patients with motor fluctuations treated with levodopa and dopamine agonists:: An analysis of four randomized trials

被引：0
|
作者：
Kuoppamäki, M
Vahteristo, M
Kieburtz, K
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P467
引用
收藏
页码：S137 / S138
页数：2
相关论文
共 50 条
  • [1] Entacapone provides additional benefit to Parkinson's disease patients with motor fluctuations treated with levodopa and selegiline
    Larsen, J
    Nissinen, H
    Vahteristo, M
    MOVEMENT DISORDERS, 2005, 20 : S114 - S114
  • [2] Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients
    Kieburtz, K
    Shoulson, I
    Fahn, S
    McDermott, M
    Koller, W
    LeWitt, P
    Nutt, J
    Kurth, M
    Brewer, M
    Lew, M
    Welsh, M
    Waters, C
    Bennett, J
    RostRuffner, E
    Feigin, A
    Gardiner, I
    Kurlan, R
    Hammerstad, J
    Stone, C
    Jankovic, J
    Beach, J
    Tetrud, J
    Kelker, K
    Standaert, DG
    Growdon, JH
    Tennis, M
    Graefe, K
    Mark, MH
    Kelly, SJ
    Pahwa, R
    McGuire, D
    Hubble, J
    Factor, SA
    Brown, DL
    Tuite, P
    Sime, E
    Lang, DL
    Greene, P
    Winfield, H
    Paulson, G
    Zoog, K
    Weeks, C
    Shults, C
    Fontaine, D
    Juncos, JL
    Wood, C
    Shannon, K
    Jaglin, JA
    Tornabene, J
    Lannon, MC
    ANNALS OF NEUROLOGY, 1997, 42 (05) : 747 - 755
  • [3] Entacapone in the treatment of motor fluctuations in patients with idiopathic Parkinson's disease
    Sommer, U
    Müller, A
    Herting, B
    Cormann, K
    Kohlert, F
    Reichmann, H
    NERVENARZT, 2002, 73 (08): : 761 - 764
  • [4] Entacapone and motor fluctuations in Parkinson's disease - Reply
    McDermott, M
    Kieburtz, K
    ANNALS OF NEUROLOGY, 1998, 44 (02) : 292 - 292
  • [5] Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study
    G. Fénelon
    S. Giménez-Roldán
    J. L. Montastruc
    F. Bermejo
    F. Durif
    I. Bourdeix
    J.-J. Péré
    L. Galiano
    J. Schadrack
    Journal of Neural Transmission, 2003, 110 : 239 - 251
  • [6] Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations.: A randomized, double-blind, multicentre study
    Fénelon, G
    Giménez-Roldán, S
    Montastruc, JL
    Bermejo, F
    Durif, F
    Bourdeix, I
    Péré, JJ
    Galiano, L
    Schadrack, J
    JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (03) : 239 - 251
  • [7] Determining the benefit of levodopa/carbidopa/entacapone (Stalevo®) on the pharmacokinetic profile of levodopa:: a randomized, crossover, multicentre study in patients with Parkinson's disease
    Marttila, R.
    Kaasinen, V.
    Hartikainen, P.
    Lyytinen, J.
    Kaakkola, S.
    Hanninen, J.
    Korpela, K.
    Laapas, K.
    Kuoppamaki, M.
    Ellmen, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 115 - 115
  • [8] Determining the benefit of levodopa/carbidopa/entacapone (Stalevo®) on the pharmacokinetic profile of levodopa:: a randomized, crossover, multicentre study in patients with Parkinson's disease
    Kaakola, S.
    Ellmen, J.
    Marttila, R.
    Kaasinen, V.
    Hartikainen, P.
    Lyytinen, J.
    Hanninen, J.
    Korpela, K.
    Kuoppamaki, M.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S100 - S100
  • [9] Determining the benefit of levodopa/carbidopa/entacapone (Stalevo®) on the pharmacokinetic profile of levodopa:: A randomized, crossover, multicenter study in patients with Parkinson's disease
    Marttila, R.
    Kaasinen, V.
    Hartikainen, P.
    Lyytinen, J.
    Kaakkola, S.
    Haenninen, J.
    Korpela, K.
    Laapas, K.
    Kuoppamaeki, M.
    Ellmen, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S213 - S213
  • [10] Current management of motor fluctuations in patients with advanced Parkinson's disease treated chronically with levodopa
    Melamed, E
    Zoldan, J
    Galili-Mosberg, R
    Ziv, I
    Djaldetti, R
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1999, (56): : 173 - 183
12345